The generic drugmaker was the top loser on the Nifty Pharma index and the benchmark Nifty 50 index. "The drop in shares comes ...

U.S. authorities indicted Adani, his nephew and Executive Director Sagar Adani and Managing Director Vneet S. Jaain, alleging that they paid bribes to secure Indian power supply contracts, and ...

Gold prices dipped on Thursday after hitting a near three-month high in the previous session, while market participants ...

Asian equities mostly rose Thursday, cheered by another tech-fuelled run-up on Wall Street after Donald Trump's huge AI ...

The dollar traded in narrow ranges against major peers on Thursday, as the currency continued to struggle for direction in ...

ZM's AI innovation, record-low churn and strong enterprise growth make it attractive despite recent gains. With $7.7 billion cash and new buybacks, the stock looks promising.

South Africa's mining industry reported 42 deaths last year, the lowest number to date and a 24% improvement on the previous year, official statistics showed on Thursday. The statistics did not ...

As Washington steels itself for a battle with China over critical minerals and Brussels struggles to beat back a flood of Chinese electric vehicles, Saudi Arabia has offered to help Beijing ride out ...

Indian generic drugmaker Dr Reddy's Laboratories reported third-quarter profit below expectations on Thursday, weighed down by pricing pressure in the competitive North American market, their biggest ...

Indian software services company Mphasis posted a bigger-than-expected rise in third-quarter profit on Thursday, aided by strong deal wins in its banking segment. The company's consolidated net profit ...

The company plans to foray into the EV charging infrastructure sector and has launched its pilot services in the business hub of Gurugram and the southern city of Bengaluru, it said in a statement.